Topics

Kangstem Soothes Investors, Finds Hope In New Trials For Furestem In Atopic Dermatitis

18:31 EDT 28 Oct 2019 | SCRIP

After the much anticipated Phase III South Korean clinical trial of its cord blood-derived stem cell therapy for atopic dermatitis...

      

Related Stories

 

Original Article: Kangstem Soothes Investors, Finds Hope In New Trials For Furestem In Atopic Dermatitis

NEXT ARTICLE

More From BioPortfolio on "Kangstem Soothes Investors, Finds Hope In New Trials For Furestem In Atopic Dermatitis"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...